Agios Pharmaceuticals Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
AGIO Nasdaq 8731 http://www.agios.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Agios Pharmaceuticals Inc

CENTOGENE and Agios Expand Partnership for Clinical Development of PYRUKYND® (mitapivat) to Treat Children With Rare Blood Disease - Jun 13th, 2022 10:30 am
Agios Presents New Clinical Data Supporting the Benefits of PYRUKYND® (mitapivat) Treatment in Adults with PK Deficiency at European Hematology Association Annual Congress - Jun 10th, 2022 2:30 pm
Agios Is Looking For Development Partner, Lays Off Exploratory Research Staff - May 17th, 2022 4:13 pm
Agios to lay off 50 as it sets its sights on later-stage drugs - May 16th, 2022 8:15 pm
Agios Announces Evolution of Research Organization - May 16th, 2022 8:15 pm
Agios to Present Clinical and Translational Data at the European Hematology Association Annual Congress - May 12th, 2022 2:00 pm
Agios to Present at the RBC Capital Markets Global Healthcare Conference on May 17, 2022 - May 10th, 2022 11:00 am
Does Agios Pharmaceuticals (NASDAQ:AGIO) Have A Healthy Balance Sheet? - May 7th, 2022 1:02 pm
Agios Pharmaceuticals (AGIO) Reports Q1 Loss, Lags Revenue Estimates - May 5th, 2022 12:15 pm
Agios Reports Business Highlights and First Quarter 2022 Financial Results - May 5th, 2022 11:00 am
Agios to Webcast Conference Call of First Quarter 2022 Financial Results on May 5, 2022 - Apr 21st, 2022 11:00 am
Agios Announces Publication of Phase 3 ACTIVATE Study in New England Journal of Medicine Demonstrating Benefits of PYRUKYND® (mitapivat) for Adults with Pyruvate Kinase Deficiency - Apr 14th, 2022 12:34 pm
New Strong Sell Stocks for March 1st - Mar 1st, 2022 1:35 pm
Agios to Participate in March Investor Conferences - Feb 28th, 2022 12:00 pm
Agios (AGIO) Loss Wider Than Expected in Q4, Revenues Nil - Feb 24th, 2022 10:49 pm
The Zacks Analyst Blog Highlights Regeneron Pharmaceuticals, Sage Therapeutics, Biogen Agios Pharmaceuticals Atara Biotherapeutics - Feb 24th, 2022 5:03 pm
Agios Pharmaceuticals (AGIO) Reports Q4 Loss, Lags Revenue Estimates - Feb 24th, 2022 1:55 pm
Agios Reports Fourth Quarter and Full Year 2021 Financial Results - Feb 24th, 2022 12:00 pm
Biotech Stock Roundup: SAGE, ATRA Down on Study Updates, AGIO Drug Approval & More - Feb 23rd, 2022 5:57 pm
Agios (AGIO) Gets FDA Nod for Rare Anemia Drug Mitapivat - Feb 18th, 2022 3:29 pm